Atlas Trials

Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)

Clinical trial NCT04525157 · COMPLETED

Trial details

NCT number
NCT04525157
Sponsor
Clinuvel Pharmaceuticals Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Vitiligo
Start date
2014-06-06
Primary completion
2016-02-02
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.